Sui G - Search Results

1

Therapeutic Application of Natural Medicine Monomers in Cancer Treatment.

Zhong C, Wall NR, Zu Y, Sui G. Zhong C, et al. Among authors: sui g. Curr Med Chem. 2017 Nov 17;24(34):3681-3697. doi: 10.2174/0929867324666170714101503. Curr Med Chem. 2017. PMID: 28714385 Review.

2

Yin Yang 1 is a negative regulator of p53.

Sui G, Affar el B, Shi Y, Brignone C, Wall NR, Yin P, Donohoe M, Luke MP, Calvo D, Grossman SR, Shi Y. Sui G, et al. Cell. 2004 Jun 25;117(7):859-72. doi: 10.1016/j.cell.2004.06.004. Cell. 2004. PMID: 15210108 Free article.

3

Yin Yang 1 regulates the transcriptional repression of Survivin.

Galloway NR, Diaz Osterman CJ, Reiber K, Jutzy JM, Li F, Sui G, Soto U, Wall NR. Galloway NR, et al. Among authors: sui g. Biochem Biophys Res Commun. 2014 Feb 28;445(1):208-13. doi: 10.1016/j.bbrc.2014.01.169. Epub 2014 Feb 4. Biochem Biophys Res Commun. 2014. PMID: 24508259 Free PMC article.

4

Ellagic acid synergistically potentiates inhibitory activities of chemotherapeutic agents to human hepatocellular carcinoma.

Zhong C, Qiu S, Li J, Shen J, Zu Y, Shi J, Sui G. Zhong C, et al. Among authors: sui g. Phytomedicine. 2019 Jun;59:152921. doi: 10.1016/j.phymed.2019.152921. Epub 2019 Apr 4. Phytomedicine. 2019. PMID: 31055231

5

Thymoquinone Selectively Induces Hepatocellular Carcinoma Cell Apoptosis in Synergism With Clinical Therapeutics and Dependence of p53 Status.

Jehan S, Zhong C, Li G, Zulqarnain Bakhtiar S, Li D, Sui G. Jehan S, et al. Among authors: sui g. Front Pharmacol. 2020 Sep 15;11:555283. doi: 10.3389/fphar.2020.555283. eCollection 2020. Front Pharmacol. 2020. PMID: 33041795 Free PMC article.

6

Transcriptome analysis of signaling pathways targeted by Ellagic acid in hepatocellular carcinoma cells.

Qiu S, Zhong C, Zhao B, Li G, Wang J, Jehan S, Li J, Zhao X, Li D, Sui G. Qiu S, et al. Among authors: sui g. Biochim Biophys Acta Gen Subj. 2021 Jul;1865(7):129911. doi: 10.1016/j.bbagen.2021.129911. Epub 2021 Apr 20. Biochim Biophys Acta Gen Subj. 2021. PMID: 33862123

7

Disruption of YY1-EZH2 Interaction Using Synthetic Peptides Inhibits Breast Cancer Development.

Yi C, Li G, Wang W, Sun Y, Zhang Y, Zhong C, Stovall DB, Li D, Shi J, Sui G. Yi C, et al. Among authors: sui g. Cancers (Basel). 2021 May 16;13(10):2402. doi: 10.3390/cancers13102402. Cancers (Basel). 2021. PMID: 34065631 Free PMC article.

8

Small Molecule Compounds of Natural Origin Target Cellular Receptors to Inhibit Cancer Development and Progression.

Wang J, Li D, Zhao B, Kim J, Sui G, Shi J. Wang J, et al. Among authors: sui g. Int J Mol Sci. 2022 Feb 28;23(5):2672. doi: 10.3390/ijms23052672. Int J Mol Sci. 2022. PMID: 35269825 Free PMC article. Review.

9

A histidine cluster determines YY1-compartmentalized coactivators and chromatin elements in phase-separated enhancer clusters.

Wang W, Qiao S, Li G, Cheng J, Yang C, Zhong C, Stovall DB, Shi J, Teng C, Li D, Sui G. Wang W, et al. Among authors: sui g. Nucleic Acids Res. 2022 May 20;50(9):4917-4937. doi: 10.1093/nar/gkac233. Nucleic Acids Res. 2022. PMID: 35390165 Free PMC article.

10

The role of YY1 in oncogenesis and its potential as a drug target in cancer therapies.

Shi J, Hao A, Zhang Q, Sui G. Shi J, et al. Among authors: sui g. Curr Cancer Drug Targets. 2015;15(2):145-57. doi: 10.2174/1568009615666150131124200. Curr Cancer Drug Targets. 2015. PMID: 25817371 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

452 results

Search Page

Filters